D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients | Zendy

Yael Becher | Zendy; Leonid Goldman | Zendy; Nadav Yehoshua Schacham | Zendy; Irina Gringauz | Zendy; Dan Justo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients

Author(s) -

Yael Becher,

Leonid Goldman,

Nadav Yehoshua Schacham,

Irina Gringauz,

Dan Justo

Publication year - 2020

Publication title -

european journal of case reports in internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.125

H-Index - 1

ISSN - 2284-2594

DOI - 10.12890/2020_001725

Subject(s) - medicine , pulmonary embolism , covid-19 , d dimer , cardiology , c reactive protein , intensive care medicine , virology , disease , inflammation , outbreak , infectious disease (medical specialty)

The diagnosis of pulmonary embolism is challenging in symptomatic COVID-19 patients since shortness of breath, chest pain, tachycardia, tachypnoea, fever, oxygen desaturation and high D-dimer blood levels might be features of both diseases. We present two COVID-19 patients in whom pulmonary embolism was suspected (and diagnosed) due to a discrepancy between an increase in D-dimer blood levels and a decrease in C-reactive protein blood levels over time. We believe that an opposite change in the blood levels of both biomarkers over time may be used as a novel method to predict pulmonary embolism in COVID-19 patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research